Sfoglia per Autore

opzioni
Mostrati risultati da 1 a 12 di 12
Titolo Data di pubblicazione Autore(i) File
Triazolophthalazines: Easily Accessible Compounds with Potent Antitubercular Activity. 1-gen-2016 Veau, D; Krykun, S; Mori, Giorgia; Orena, BEATRICE SILVIA; Pasca, MARIA ROSALIA; Frongia, C; Lobjois, V; Chassaing, S; Lherbet, C; Baltas, M.
Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis. 1-gen-2016 Matviiuk, T; Madacki, J; Mori, Giorgia; Orena, BEATRICE SILVIA; Menendez, C; Kysil, A; André Barrès, C; Rodriguez, F; Korduláková, J; Mallet Ladeira, S; Voitenko, Z; Pasca, MARIA ROSALIA; Lherbet, C; Baltas, M.
New and old hot drug targets in tuberculosis 1-gen-2016 Chiarelli, Laurent; Mori, Giorgia; Esposito, Marta; Orena, BEATRICE SILVIA; Pasca, MARIA ROSALIA
A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors 1-gen-2017 Esposito, Marta; Szadocka, Sára; Degiacomi, Giulia; Orena, BEATRICE SILVIA; Mori, Giorgia; Piano, Valentina; Boldrin, Francesca; Zemanova, Julia; Huszár, Stanislav; Barros, David; Ekins, Sean; Lelièvre, Joël; Manganelli, Riccardo; Mattevi, Andrea; Pasca, MARIA ROSALIA; Riccardi, Giovanna; Ballell, Lluis; Mikušová, Katarína; Chiarelli, Laurent
Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity. 1-gen-2017 Oliveira, Pfm; Guidetti, B; Chamayou, A; André Barrès, C; Madacki, J; Korduláková, J; Mori, Giorgia; Orena, BEATRICE SILVIA; Chiarelli, Laurent; Pasca, MARIA ROSALIA; Lherbet, C; Carayon, C; Massou, S; Baron, M; Baltas, M.
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 1-gen-2018 Chiarelli, L; Mori, G; Orena, Bs; Esposito, M; Lane, T; de Lopes Jesus Ribeiro, Al; Degiacomi, G; Zemanova, J; Szadocka, S; Huszar, S; Palcekova, Z; Manfredi, M; Gosetti, F; Lelievre, J; Ballell, L; Kazakova, E; Makarov, V; Marengo, E; Mikusova, K; Cole, St; Riccardi, G; Ekins, S; Pasca, Mr
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 1-gen-2018 Mori, G; Orena, Bs; Franch, C; Mitchenall, La; Godbole, Aa; Rodrigues, L; Aguilar-Pérez, C; Zemanová, J; Huszár, S; Forbak, M; Lane, Tr; Sabbah, M; Deboosere, N; Frita, R; Vandeputte, A; Hoffmann, E; Russo, R; Connell, N; Veilleux, C; Kumar, R; Kumar, P; Freundlich, Js; Brodin, P; Aínsa, Ja; Nagaraja, V; Maxwell, A; Mikušová, K; Pasca, Mr; Ekins, S.
New antitubercular prodrugs with novel mechanisms of action 27-feb-2018 Orena, BEATRICE SILVIA
Pyrazole and imidazo[1,2-b]pyrazole derivatives as new potential anti-tuberculosis agents. 1-gen-2019 Meta, E; Brullo, C; Tonelli, M; Franzblau, Sg; Wang, Y; Ma, R; Baojie, W; Orena, Bs; Pasca, Mr; Bruno, O.
Gut Microbiota Analysis in Postoperative Lynch Syndrome Patients 1-gen-2019 Mori, G; Orena, Bs; Cultrera, I; Barbieri, G; Albertini, Am; Ranzani, Gn; Carnevali, I; Tibiletti, Mg; Pasca, Mr
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053 1-gen-2020 Chiarelli, Lr; Salina, Eg; Mori, G; Azhikina, T; Riabova, O; Lepioshkin, A; Grigorov, A; Forbak, M; Madacki, J; Orena, Bs; Manfredi, M; Gosetti, F; Buzzi, A; Degiacomi, G; Sammartino, Jc; Marengo, E; Korduláková, J; Riccardi, G; Mikušová, K; Makarov, V; Pasca, Mr.
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 1-gen-2020 Mori, G; Silvia Orena, B; Chiarelli, Lr; Degiacomi, G; Riabova, O; Sammartino, Jc; Makarov, V; Riccardi, G; Pasca, M
Mostrati risultati da 1 a 12 di 12
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile